Celcuity (CELC) Depreciation & Amortization (CF) (2016 - 2025)
Celcuity (CELC) reported Depreciation & Amortization (CF) of $82000.0 for Q4 2025, up 1540.0% on a YoY basis from $5000.0 in Q4 2024, and up 100.0% quarter-over-quarter from $41000.0 in Q3 2025.
Celcuity (CELC) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends
Celcuity has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $82000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 1540.0% year-over-year to $82000.0; the trailing twelve-month figure through Dec 2025 stood at $200000.0 (up 100.0% YoY), and the FY2025 full-year result was $200000.0, up 100.0% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $82000.0, up from $41000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $98222.0 in Q1 2021, with the low at $5000.0 in Q4 2024.
- Historically, Depreciation & Amortization (CF) has averaged $47846.2 across 5 years, with a median of $42469.0 in 2023.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) tumbled 82.11% — and 2025, when it jumped 1540.0%.
- Celcuity's Depreciation & Amortization (CF) stood at $63029.0 in 2021, then retreated by 22.36% to $48937.0 in 2022, then tumbled by 42.89% to $27948.0 in 2023, then plunged by 82.11% to $5000.0 in 2024, then surged by 1540.0% to $82000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $82000.0 (Q4 2025), $41000.0 (Q3 2025), and $40000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 429,663.65 |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 27,948.00 |
| Dec 31, 2023 | 27,948.00 |
| Sep 30, 2023 | 33,555.00 |
| Sep 30, 2023 | 33,555.00 |